𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

✍ Scribed by Anders Österborg; Yvonne Brandberg

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
67 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

DOI 10.1002/cncr.11430

📜 SIMILAR VOLUMES

Relationship between changes in hemoglob
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
✍ Jeffrey Crawford; David Cella; Charles S. Cleeland; Pierre-Yves Cremieux; George 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Background: Hemoglobin increases have been associated with quality of life (qol) improvements in anemic cancer patients treated with epoetin alfa, but intervention generally has been reserved for symptomatic anemia or hemoglobin < 10 g/dl. relationships among hemoglobin, functional status, and p

Epoetin alfa improves quality of life in
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy
✍ Paul J. Pockros; Mitchell L. Shiffman; Eugene R. Schiff; Mark S. Sulkowski; Zoba 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Anemia and decreased health-related quality of life (HRQL) are common in patients receiving combination therapy of interferon alfa (IFN) and ribavirin (RBV) for chronic hepatitis C virus (HCV) infection. In a randomized, prospective study evaluating the effectiveness of epoetin alfa in maintaining R

Once-weekly dosing of epoetin-α increase
Once-weekly dosing of epoetin-α increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy
✍ Daniel Shasha; Martine J. George; Louis B. Harrison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract ## BACKGROUND The current study was performed to prospectively evaluate the effectiveness, clinical outcomes, and safety of once‐weekly (QW) recombinant human erythropoietin (r‐HuEPO [epoetin‐α]) in anemic cancer patients with nonmyeloid malignancies who were receiving radiation therap